Mercer Global Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.05M Buy
61,727
+33,961
+122% +$5.08M 0.01% 675
2026
Q2
$4.23M Buy
27,766
+10,460
+60% +$1.74M 0.01% 952
2026
Q1
$3.63M Buy
17,306
+11,622
+204% +$2.92M 0.01% 908
2025
Q4
$1.62M Buy
5,684
+1,236
+28% +$386K ﹤0.01% 1216
2025
Q3
$1.37M Buy
4,448
+2,041
+85% +$639K ﹤0.01% 1213
2025
Q2
$756K Buy
2,407
+396
+20% +$114K ﹤0.01% 1351
2025
Q1
$528K Buy
2,011
+966
+92% +$261K ﹤0.01% 1444
2024
Q4
$273K Buy
1,045
+1
+0.1% +$252 ﹤0.01% 1804
2024
Q3
$245K Buy
1,044
+260
+33% +$53.4K ﹤0.01% 1698
2024
Q2
$673K Buy
+784
New +$141K ﹤0.01% 1154

Other funds holding PODD

Mercer Global Advisors's PODD Position: Q3 2026 in Review

Mercer Global Advisors increased its Insulet (PODD) stake by 122% in Q3 2026, buying an estimated $5.08M and bringing the position to 61,727 shares worth $8.05M. The position accounts for 0.01% of the portfolio, ranked #675.

Mercer Global Advisors first reported a position in PODD in Q2 2024 and has held it in 10 quarters since. 694 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Mercer Global Advisors held 61,727 shares of Insulet worth $8.05M as of Q3 2026.
  • Mercer Global Advisors bought 33,961 Insulet shares in Q3 2026, an estimated $5.08M.
  • Insulet made up 0.01% of Mercer Global Advisors's portfolio in Q3 2026, its #675 holding.
  • Mercer Global Advisors first reported a position in Insulet in Q2 2024 and has held it in 10 quarters since.
  • 694 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Mercer Global Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.